Latest News & Features
Europe
Elkington + Fife has unveiled Mark Scott as a new partner in the UK firm’s patent practice. 13 May 2019
Americas
The Food and Drug Administration has issued final guidance on the pathway for ‘interchangeable’ biosimilar products, in a bid to promote competition in the biologics market. 13 May 2019
Big Pharma
Novartis is set to acquire assets associated with Xiidra ((lifitegrast ophthalmic solution), a dry eye treatment, from Takeda. 10 May 2019
Americas
ACI’s 17th Global Summit on Life Sciences Patents returns to New York on May 15-17, 2019, to provide practical insights on how to maximise your patent term and develop strategies to enhance protections for your patent portfolio. 9 May 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, May 8, rejected an appeal from Amgen in patent litigation relating to two Sandoz biosimilars. 9 May 2019
Americas
A generic version of Gilead’s Truvada will hit the market in 2020, a year earlier than expected. 9 May 2019
Biotechnology
Danish pharmaceutical company Lundbeck will acquire Abide Therapeutics, it has been announced. 8 May 2019
Biotechnology
A former scientist at Bayer CropScience shared confidential information with his new employer, which was used to develop commercial biopesticide products, according to a claim filed by the agricultural company. 8 May 2019
Big Pharma
One of Allergan’s patents has been invalidated after it was challenged by UK-based pharmaceutical companies Accord Healthcare and Aspire Pharma. 7 May 2019
Americas
British drugmaker Vectura has succeeded in its patent litigation against fellow UK pharmaceutical company GlaxoSmithKline over a series of drugs delivered through GSK’s ‘Ellipta’ dry powder inhaler. 7 May 2019